Quality of Chinese CVD medication apps

Yisi Liu, Polun Chang, Nan Li, Karen V. Lamb, Jiani Wang, Xiuxiu Huanga, Yi Wang, Ying Wu*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

3 Scopus citations

Abstract

The quality of Chinese cardiovascular disease medication apps was evaluated and compared to those in the Google Play Store. Only 21% of 257 CVD medication apps covered medication issues, but the quality is in question. The quality of top 10 CVD medication apps from China was inferior to international apps. An app quality assurance mechanism is needed to ensure patient safety.

Original languageEnglish
Title of host publicationNursing Informatics 2016 - eHealth for All
Subtitle of host publicationEvery Level Collaboration - From Project to Realization
EditorsWalter Sermeus, Patrick Weber, Paula M. Procter
PublisherIOS Press
Pages1036-1037
Number of pages2
ISBN (Electronic)9781614996576
DOIs
StatePublished - 2016
Event13th International Conference on Nursing Informatics, NI 2016 - Geneva, Switzerland
Duration: 25 Jun 201629 Jun 2016

Publication series

NameStudies in Health Technology and Informatics
Volume225
ISSN (Print)0926-9630
ISSN (Electronic)1879-8365

Conference

Conference13th International Conference on Nursing Informatics, NI 2016
Country/TerritorySwitzerland
CityGeneva
Period25/06/1629/06/16

Keywords

  • Application
  • Cardiovascular disease
  • Medication
  • Mhealth

Fingerprint

Dive into the research topics of 'Quality of Chinese CVD medication apps'. Together they form a unique fingerprint.

Cite this